These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
3. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization]. Santiago-Delefosse M; Cahen F; Coeffin-Driol C Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699 [TBL] [Abstract][Full Text] [Related]
4. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Griebsch I; Coast J; Brown J Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of group psychotherapy for depression in Uganda. Siskind D; Baingana F; Kim J J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302 [TBL] [Abstract][Full Text] [Related]
6. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE; Kleijnen J Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [TBL] [Abstract][Full Text] [Related]
7. Appraisal of primary outcome measures used in trials of patient decision support. Kryworuchko J; Stacey D; Bennett C; Graham ID Patient Educ Couns; 2008 Dec; 73(3):497-503. PubMed ID: 18701235 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness as an outcome in randomized clinical trials. Hlatky MA; Owens DK; Sanders GD Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039 [TBL] [Abstract][Full Text] [Related]
9. Information technology and the inferential gap. Perlin JB; Kupersmith J Health Aff (Millwood); 2007; 26(2):w192-4. PubMed ID: 17259203 [TBL] [Abstract][Full Text] [Related]
10. Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service. Marchetti M; Caruggi M; Colombo G Clin Ther; 2004 Sep; 26(9):1546-61. PubMed ID: 15531017 [TBL] [Abstract][Full Text] [Related]
11. [Quasi experimental evaluation of public health interventions (author's transl)]. Patrick DL Rev Epidemiol Sante Publique; 1981; 29(3):245-53. PubMed ID: 7302309 [TBL] [Abstract][Full Text] [Related]
12. The limitations of randomized controlled trials in predicting effectiveness. Cartwright N; Munro E J Eval Clin Pract; 2010 Apr; 16(2):260-6. PubMed ID: 20367845 [TBL] [Abstract][Full Text] [Related]
14. Cautionary tales in the interpretation of observational studies of effects of clinical interventions. Scott IA; Attia J Intern Med J; 2017 Feb; 47(2):144-157. PubMed ID: 27345967 [TBL] [Abstract][Full Text] [Related]
15. How should cost data in pragmatic randomised trials be analysed? Thompson SG; Barber JA BMJ; 2000 Apr; 320(7243):1197-200. PubMed ID: 10784550 [No Abstract] [Full Text] [Related]
18. Evidence-based radiology: why and how? Sardanelli F; Hunink MG; Gilbert FJ; Di Leo G; Krestin GP Eur Radiol; 2010 Jan; 20(1):1-15. PubMed ID: 20069736 [TBL] [Abstract][Full Text] [Related]
19. [Economic assessment, a field between clinical research and observational studies]. Launois R Bull Cancer; 2003 Jan; 90(1):97-104. PubMed ID: 12609811 [TBL] [Abstract][Full Text] [Related]